Watch the recording from the first in our three-part series designed for First‑Time Launch teams preparing for their first commercial launch.
This session explored common blind spots such as data integrity, audit readiness, and system maturity and explained why these issues frequently remain hidden until just before launching.
The discussion also contrasted traditional CSV approaches with a CSA‑based, risk‑focused assurance model, highlighting how CSA can reduce validation effort while strengthening inspection readiness and supporting a more confident launch.
Download: Operational Blind Spots: The Quality Risks That Jeopardize Commercial Launch
A unique, collaborative forum for leaders in emerging biotech companies—from pre-IND to first launch, partnership, or acquisition